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ABSTRACT
A comparative genomic approach was used to
reconstruct transcriptional regulation of NAD
biosynthesis in bacteria containing orthologs of
Bacillus subtilis gene yrxA, a previously identified
niacin-responsive repressor of NAD de novo synthe-
sis. Members of YrxA family (re-named here NiaR)
are broadly conserved in the Bacillus/Clostridium
group and in the deeply branching Fusobacteria and
Thermotogales lineages. We analyzed upstream
regions of genes associated with NAD biosynthesis
to identify candidate NiaR-binding DNA motifs and
assess the NiaR regulon content in these species.
Representatives of the two distinct types of candi-
date NiaR-binding sites, characteristic of the
Firmicutes and Thermotogales, were verified by an
electrophoretic mobility shift assay. In addition to
transcriptional control of the nadABC genes, the
NiaR regulon in some species extends to niacin
salvage (the pncAB genes) and includes uncharac-
terized membrane proteins possibly involved in
niacin transport. The involvement in niacin uptake
proposed for one of these proteins (re-named NiaP),
encoded by the B. subtilis gene yceI, was experi-
mentally verified. In addition to bacteria, members
of the NiaP family are conserved in multicellular
eukaryotes, including human, pointing to possible
NaiP involvement in niacin utilization in these
organisms. Overall, the analysis of the NiaR and
NrtR regulons (described in the accompanying
paper) revealed mechanisms of transcriptional
regulation of NAD metabolism in nearly a hundred
diverse bacteria.
INTRODUCTION
Nicotinamide adenine dinucleotide (NAD) plays an
important role in cellular metabolism because it functions
as a cofactor of numerous redox reactions and is utilized
as a consumable substrate by several classes of NAD-
dependent enzymes such as DNA ligase, protein deacety-
lase and a variety of ADP-ribosyltransferases (1–3). The
biochemistry, enzymology and genetics of NAD metabo-
lism were studied in a number of model species as reﬂected
in numerous overviews [e.g. see (4–9)]. In many bacteria,
NAD is synthesized de novo from aspartic acid by the
consecutive action of L-aspartate oxidase NadB, quinoli-
nate synthetase NadA, quinolinate phosphorybosyltrans-
ferase NadC, nicotinate mononucleotide (NaMN)
adenylyltransferase NadD and NAD synthetase NadE
(Figure 1A). Mononucleotide intermediates, NaMN and
its amidated analog (NMN), can be generated via a
variety of salvage/recycling pathways from nicotinamide
(Nam), nicotinic acid (NA) or ribosyl nicotinamide
(RNam). Both Nam and NA (often indiscriminately
referred to as vitamin B3 or niacin) can originate from
exogenous sources via relatively poorly studied uptake
mechanisms, as well as via the breakdown of endogenous
NAD by NAD-consuming enzymes. The most widely
distributed niacin salvage pathway is a two-step conver-
sion of Nam to NaMN via nicotinamidase PncA and
nicotinate phosphoribosyltransferase PncB. Alternatively,
Nam can be converted to NMN by nicotinamide
phosphoribosyltransferase NadV. Another salvage
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RNam uptake via the PnuC transporter and phosphor-
ylation by the RNam kinase domain of the multifunc-
tional NadR protein (10). The ultimate conversion of
NMN intermediate to NAD is performed by the NMN
adenylyltransferase domain of the NadR or NadM family
[as in Haemophilus inﬂuenzae (11), or Synechocystis sp. (6),
respectively].
In contrast with a rather detailed picture of NAD-
related biosynthetic pathways in diverse bacteria, the
knowledge of transcriptional regulation of these pathways
until recently was limited to Enterobacteria. The NadR
protein of Escherichia coli and Salmonella was shown to
function as a NAD-responsive repressor of NAD de novo
and salvage pathways (12–14). An optional N-terminal
HTH-domain of a multifunctional NadR protein mediates
speciﬁc recognition of a palindromic 18-bp operator with
the consensus sequence TGTTTA-N6-TAAACA. A com-
parative genomic analysis revealed conserved NadR-
binding DNA motifs and allowed us to reconstruct the
NadR regulon (including autoregulation of the nadR
gene) in the Enterobacteria (15). NadR orthologs in
bacterial lineages beyond the Enterobacteria lack the
N-terminal DNA-binding domain, and they apparently
function only as RNam salvage enzymes and not as
transcriptional regulators.
A novel transcriptional regulator of NAD biosynthesis
was recently discovered in Bacillus subtilis (16). This
regulator encoded by the yrxA gene was shown to be an
NA-responsive transcriptional repressor of two diver-
gently transcribed operons, nadBCA and nifS-yrxA, with
overlapping promoters (17). In this study, we used a
comparative genomic approach to reconstruct this novel
regulon (re-named here NiaR, for niacin repressor) in
many species of the Bacillus/Clostridium group and in the
deep-branched Fusobacteria and Thermotogales lineages
that contain orthologs of the niaR (yrxA) genes in their
genomes. The approach combining metabolic reconstruc-
tion with analysis of genome context and conserved
upstream regions was successfully applied by us and
other research groups to expand known regulons to a
broad range of related species as well as to predict
regulons ab initio [for a recent review see (18)]. Moreover,
such analysis generates tentative functional assignments of
previously uncharacterized genes that in many cases have
been already conﬁrmed by further experimental studies.
Reconstruction of regulons associated with metabolic
pathways is a particularly eﬃcient strategy for predicting
new transporter speciﬁcities (19).
In this study we tentatively identiﬁed two distinct NiaR-
binding DNA motifs: type I (with the TGT-N4-ACA core)
characteristic of the entire Bacillus/Clostridium group and
the Fusobacteria lineage; and type II (with an ACA-N5-
TGT core), found exclusively in Thermotogales. Predicted
DNA sites were experimentally veriﬁed by electrophoretic
mobility shift assays (EMSAs) for two sites of each type I
(in B. subtilis) and II (in Thermotoga maritima) genomes,
using puriﬁed recombinant proteins YrxA (bsNiaR) and
TM1602 (tmNiaR) respectively. In addition to NAD de
novo synthesis genes, the NiaR regulon in these divergent
species includes conserved homologous genes encoding
uncharacterized membrane proteins (YceI in B. subtilis
and TM1603 in T. maritima) of the Major Facilitator
Superfamily (MFS). The hypothesized role of this
AB
Figure 1. NAD biogenesis and its transcriptional regulation in bacteria containing NiaR regulator. (A) A simpliﬁed pathway diagram showing
biochemical transformations (arrows) of precursors and intermediates (shown by the same abbreviations as in the text). Dashed arrows reﬂect uptake
of exogenous precursors. Enzymes and transporters are shown using the respective gene names in boxes whose colors correspond to various pathways
of NAD metabolism. Magenta-colored lines point to regulated genes (NrtR regulon members). (B) Genomic organization of the niaR-containing loci
and NiaR-regulated genes in representative bacterial genomes. Genes are shown by arrows colored as in Figure 1A. Red circles and squares mark
positions of candidate NiaR-binding sites of types I and II, respectively. (C) Sequence logos for the NiaR-binding motifs in the Bacillus/Clostridium
group and the Thermotogales. The colors of arrows representing reactions in (A) and genes in (B) correspond to cellular functions listed in
the legend.
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was conﬁrmed by a series of growth experiments using
B. subtilis yceI knockout mutant and recombinant strains
of E. coli overexpressing this gene. Overall, the results of
this study provide insights in two relatively poorly
explored aspects of bacterial NAD metabolism, transcrip-
tional regulation and vitamin B3 transport.
MATERIALS AND METHODS
Bioinformatic analysis ofbacterial genomes and
reconstruction ofNiaR regulon
Bacterial genome sequences were taken mainly from
GenBank (20). Some draft genomes were downloaded
from the web sites of J. Craig Venter Institute (http://
www.tigr.org), the Wellcome Trust Sanger Institute
(http://www.sanger.ac.uk) and the DOE Joint Genome
Institute (http://jgi.doe.gov). Functional annotations of
genes involved in NAD metabolism and related pathways
in bacterial genomes were from the collection of metabolic
subsystems in the SEED comparative genomic database
(21). Functional coupling of genes via clustering on the
chromosome and distribution of genes in the genomes
were analyzed using the integrated SEED tools. Multiple
sequence alignments of protein sequences were produced
by the Clustal series of program (22). The PHYLIP
package was used for construction of maximum likelihood
phylogenetic tree for the NiaR and NiaP protein families
including bootstrapping with 100 replicates and drawing
of a consensus tree (23). The Protein Families database
(http://www.sanger.ac.uk/Software/Pfam/) (24) and the
Clusters of Orthologous Groups database (http://
www.ncbi.nlm.nih.gov/COG/) (25) were used to identify
conserved functional domains. Transmembrane segments
(TMSs) in proteins were predicted using TMpred (http://
www.ch.embnet.org/software/TMPRED_form.html).
To identify candidate DNA-binding motifs of
NiaR(YrxA) regulators, we started from a set of upstream
regions of potentially coregulated genes in the Bacillus/
Clostridium group. The training set included potential
regulatory regions of genes implicated in NAD biosynthe-
sis and/or genes positionally clustered with the niaR genes.
An iterative motif detection procedure implemented in the
program SignalX was used to identify a common
regulatory DNA motif (type I) in the training set and to
construct a motif recognition proﬁle [for details see (26)].
The constructed recognition proﬁle was used to scan a
subset of the Bacillus/Clostridium genomes encoding NiaR
orthologs. A divergent NiaR-binding motif (type II)
characteristic of Thermotogales was determined by
comparing upstream regions of the nadB and yrxA genes
from four available Thermotoga genomes, T. maritima,
Thermotoga lettingae, Thermotoga neapolitana and
Thermotoga petrophila, and the DNA-recognition proﬁle
was constructed using the SignalX program. Positional
nucleotide weights in the recognition proﬁle and Z-scores
of candidate sites were calculated as the sum of the
respective positional nucleotide weights as previously
described ref. (27). Genome scanning for additional
candidate NiaR-binding sites was performed using the
Genome Explorer software (28). The threshold for the site
search was deﬁned as the lowest score observed in the
training set. Sequence logos for the derived DNA-binding
motifs were constructed using the WebLogo package v.2.6
(http://weblogo.berkeley.edu/) (29).
Expression andpurification ofrecombinant NiaR proteins
The gene yrxA was PCR-ampliﬁed from B. subtilis
genomic DNA using the primers: 50-ctcggatccTTGACC
GAAGAATTAAAGCTAATGGGCGCC (forward) and
50-ctcctcgagTTAATTAAAAATGCCGGCTTCTTCGA
GGGC (reverse). This gene was then cloned into the pHis-
parellel1 vector (30) between the BamHI and XhoI sites.
The encoded recombinant protein (bsNiaR) was over-
expressed in E. coli BL21(DE3) in the LB medium in
shake ﬂasks with induction by 0.8mM IPTG at
OD600 0.6 followed by overnight shaking at 188C, 175
r.p.m. The cells were lyzed, and the protein was extracted
by 20mM HEPES pH 7.2, 100mM NaCl, 0.03% Brij35
buﬀer containing protease inhibitor cocktail (Sigma) and
puriﬁed by Ni–NTA column chromatography. The His6-
tag was removed by treatment with TEV protease over-
night at 48C in a dialysis bag (50mM HEPES pH. 8.0
50mM NaCl buﬀer). The processed bsNiaR was recov-
ered from the ﬂow-through of the second Ni–NTA
column, concentrated and further puriﬁed by gel-ﬁltration
on a Superdex75 16/60 column using the AKTA FPLC
system. The protein eluted as a dimer with the apparent
Mr 43kDa. It was homogenous by SDS–PAGE
(Figure S1 in Supplementary Data available online) and
formed diﬀractable crystals that were further used for
structural studies (Zhang,H., unpublished data).
An E. coli DL41 strain carrying T. maritima gene
encoding tmNiaR (TM1602) in pMH2T7 vector under
arabinose-inducible promoter (31) was a kind gift from Dr
Scott Lesley at the Joint Center for Structural Genomics
(www.jcsg.org). Protein expression was performed in TB
media (24g/l yeast extract, 12g/l tryptone) containing 1%
glycerol and 50mM Mops, pH 7.6. The cells were induced
by 0.15% arabinose and harvested after 3h shaking at
378C. Puriﬁcation of the recombinant tmNiaR containing
an N-terminal His6-tag was performed using rapid
Ni–NTA agarose (Qiagen) minicolumn protocol as
described (32). Brieﬂy, harvested cells were resuspended
in 20mM HEPES buﬀer pH 7 containing 100mM NaCl,
0.03% Brij 35 and 2mM b-mercaptoethanol supplemen-
ted with 2mM phenylmethylsulfonyl ﬂuoride and a pro-
tease inhibitor cocktail (Sigma–Aldrich). Lysozyme was
added to 1mg/ml, and the cells were lyzed by freezing–
thawing followed by sonication. After centrifugation at
18000r.p.m., the Tris–HCl buﬀer (pH 8) was added to the
supernatant (50mM, ﬁnal concentration), and it was
loaded onto a Ni–NTA minicolumn (0.2ml). After
washing with the starting buﬀer containing 1M NaCl
and 0.3% Brij-35, bound proteins were eluted with 0.3ml
of the starting buﬀer containing 250mM imidazole. The
buﬀer was then changed to 20mM HEPES containing
2mM DTT, 0.5mM EDTA and 150mM NaCl by using
Bio-Spin columns (Bio-Rad). This simpliﬁed proce-
dure allowed us to obtain protein of >90% purity
2034 Nucleic Acids Research, 2008, Vol. 36, No. 6by SDS–PAGE (Supplementary Figure S1) in an amount
suﬃcient ( 2mg) for further functional studies.
Analysis ofNiaR–DNA interactions by EMSA
Interaction of puriﬁed recombinant proteins bsNiaR and
tmNiaR with their cognate DNA motifs was assessed by
the EMSA technique using the following dsDNA segments
obtained by PCR ampliﬁcation or by custom synthesis of
both complementary strands, annealing and puriﬁcation
(Allele Inc., CA, USA), as indicated below. The PCR pro-
ductswerepuriﬁedwiththePCRpuriﬁcationkit(Promega,
WI, USA), and their concentration was determined
spectrophotometrically (Nanodrop ND-1000, DE, USA).
(i) bs_nadB_87, an 87-bp segment of B. subtilis from the
upstream region of nadB gene, identical to the one
experimentally veriﬁed in previously published study
(16), was obtained by PCR ampliﬁcation with primers
50-CCTCCTGTTGTTTACACCTGTCT (forward)
and 50-CTTCCATCCGTTCTCCATAAAA (reverse)
and used as a positive control of bsNiaR binding;
(ii) bs_niaP_87, a synthetic 87-bp fragment correspond-
ing to positions ( 13 to  99) in the upstream
region of B. subtilis niaP gene (yceI), was used to
test bsNiaR binding;
(iii) tm_nadB_68, a synthetic 68-bp DNA segment cor-
responding to positions ( 3t o 65) in the upstream
region of T. maritima nadB gene (TM1643), was
used to test tmNiaR binding;
(iv) tm_niaR_68, a synthetic 68-bp DNA segment
corresponding to positions ( 6t o 62) in the
upstream region of T. maritima niaR gene
(TM1602), was used to test tmNiaR binding;
(v) tm_pncA_111, a 111-bp segment from the upstream
region of T. maritima ortholog of pncA gene
(TM0475), was obtained by PCR ampliﬁcation
using T. maritima MSB8 genomic DNA and primers
50-GCTAAGGAGCCGGTCTTGAA (forward) and
50-CACGTTTTCACCCCCTAAAA (reverse). This
fragment lacking a NiaR-binding site was used as
negative control (nonspeciﬁc competitor) in all
binding studies. A size diﬀerence between this and
other fragments was suﬃcient to monitor diﬀeren-
tial binding and gel-shift in a mixture of two DNA
fragments without labeling (see below).
A typical reaction mixture for binding studies contained
two DNA fragments (including the negative control
tm_pncA_111), each at 20nM, in a total volume of 10ml
of 20mM Tris–HCl (pH 8.0), 5mM MgCl2, 100mM KCl,
10% (v/v) glycerol, 0.5mM DTT with or without 0.3mM
NA [as in (16)]. Recombinant proteins corresponding to
the tested DNA segments were added: bsNiaR (20mM) or
tmNiaR (in a range 0–40mM), and incubated for 30min at
ambient temperature or at 758C, respectively. The com-
plex formation was monitored by the electorphoresis in
10% PAAG (with or without 0.3mM NA) at 90V using
0.5  TBE buﬀer (45mM Tris base, 45mM boric acid,
10mM EDTA). The gels were subsequently stained with
Syber Green I according to the instructions of the supplier
(Sigma–Aldrich, USA).
Testingthe proposed role of bsNiaP in niacin uptake
by growth experiments
Cloning of B. subtilis gene yceI (niaP). The gene was
PCR-ampliﬁed from B. subtilis genomic DNA using the
primers 50-gaagaccATGGGAAAACAACAGCC (for-
ward), and 50-cCTATTCTAGCTCAGTTTGTTTCGT
TTC (reverse) and cloned in pBAD TOPO TA expression
vector (Invitrogen) under control of the arabinose-
inducible promoter.
Growth studies of E. coli (nadA
 ) overexpressing the
B. subtilis gene yceI on limiting concentrations of
Nam. The expression plasmid described above was
transformed into the E. coli BW25113 (nadA) knockout
mutant with disrupted NAD de novo synthesis pathway
from the Keio collection (a kind gift by Dr H. Mori, Keio
University, Japan) (33). The same host strain containing
the expression vector without any insert was used as a
negative control. Growth curves of both strains were
obtained in the minimal M9 growth media containing
20mM glucose, 50mg/l ampicillin and 0.15% of
L-arabinose and supplemented with limiting concentra-
tions of Nam. Starter cultures were grown overnight in LB
medium. Cells were harvested, washed resuspended in the
medium (OD600 0.03), and used in equal amounts to start
growth experiments in a series of duplicates with increas-
ing concentrations of Nam in a range of 0–0.8mM. The
growth was monitored by OD600 measurement using
a microplate reader DTX800 (Beckman).
Growth studies of E. coli (nadA
+) overexpressing the
B. subtilis gene yceI in the presence of 6-Amino-Nam. The
same expression plasmid was transformed into the E. coli
BW25113 (xylF) knockout mutant from the Keio
collection. This host strain was chosen to have an
undisrupted de novo NAD pathway in a similar genetic
background as in the Nam experiments. The same E. coli
strain containing the expression vector without any insert
was used as a negative control. Growth curves for both
strains were obtained using the same approach and in
the same medium without Nam in a series of increasing
concentrations of its toxic analog, 6-Amino-Nam
(6ANam) in the range of 0–150mM.
Growth studies of B. subtilis yceI knockout strain in the
presence of 6ANam. Growth curves were obtained for
B. subtilis (yceI
 ) and compared to B. subtilis (ypaA
 )
strain used as an isogenic negative control. Both knockout
strains were from the collection constructed by the joint
eﬀort of the Japanese and European Bacillus Subtilis
Functional Analysis programs. They were obtained by a
standard single crossover-based protocol using PCR-
ampliﬁed fragments of target genes cloned in pMUTIN2
vector as previously described (34). Both strains were
grown at 378C in chemically deﬁned medium containing
glucose (4g/l), tryptophan (50mg/l), glutamine (2g/l),
K2HPO4 (10g/l), KH2PO4 (6g/l), sodium citrate (1g/l),
MgSO4 (0.2g/l), K2SO4 (2g/l), FeCl3 (4mg/l) and MnSO4
(0.2mg/l) overnight in the presence of 0.5mg/l erythro-
mycin (pMUTIN2 marker). These cultures were diluted
 10–20-fold to the same cell density (OD600=0.05) in the
Nucleic Acids Research, 2008, Vol. 36, No. 6 2035fresh medium and grown in duplicate series containing
increasing concentrations of 6ANam (0 75mM) in
duplicates. A similar experiment was performed using
another toxic niacin analog, 6-aminonicotinic acid
(6ANA), instead of 6ANam.
RESULTS
Comparative genomicreconstruction of NiaR regulon in
bacteria
The main goal of this study was to reﬁne and expand the
knowledge of transcriptional regulation of NAD synthesis
from B. subtilis, where the function of NiaR (YrxA)
as NA-responsive repressor was discovered (16), to all
bacteria that encode NiaR orthologs in their genomes.
This was done using the subsystems-based approach to
comparative genome analysis as supported by the SEED
genomic annotation platform (21), in combination with
specialized software tools for the identiﬁcation of regula-
tory DNA motifs, SignalX and Genome Explorer (28).
Taxonomic distribution and structural features of the NiaR
(YrxA) protein family. Members of the NiaR family
show a mosaic distribution among Gram-positive bacteria
from the Bacillus/Clostridium (Firmicutes) group (see
Table 1, Supplementary Table S1 and ‘NAD regulation’
subsystem in the SEED database available online
at http://theseed.uchicago.edu/FIG/index.cgi for more
details). Among other taxonomic groups, NiaR was only
found in two deeply diverged bacterial lineages, the
Thermotogales and the Fusobacteria. Like several other
Table 1. Occurrence and features of genes involved in NAD metabolism in representative bacterial genomes
The Bacillus/Clostridium, Thermotogales and Fusobacteria lineages that include species having the NiaR regulon are shown. The presence (+) or
absence (0) of the NiaR regulator is denoted in the second column. Genes clustered on the chromosome are marked by the same background color.
Candidate NiaR regulon members are circled. II denotes a nonorthologous substitution of the aspartate oxidase NadB by the aspartate
dehydrogenase NadB-II in Thermotogales.
2036 Nucleic Acids Research, 2008, Vol. 36, No. 6transcription factors, e.g. NrdR (35) and ArgR (36),
regulators from the NiaR family always occur as a single
copy pointing to a likely functional homogeneity of
this family. Although a maximum-likelihood tree of the
entire NiaR family is in good overall correlation with the
phylogenetic tree of bacterial species, some deviations
were observed (Figure 2A). For example, the NiaR
proteins from two Streptococcus species, Streptococcus
thermophilus and Streptococcus pneumoniae, branch
together with Clostridiales, whereas all other
Streptococci occur on a distinct Lactobacillales branch.
The ﬁrst 3D structure from the NiaR family was solved
and reported for tmNiaR, the TM1602 protein from
T. maritima (PDB accession number 1J5Y) by the Joint
Center for Structural Genomics [www.jcsg.org, (37)]. The
TM1602 monomer consists of two structural domains
(Figure 2B), an N-terminal domain similar to the ‘winged
helix’ DNA-binding domain of the biotin repressor BirA,
and a C-terminal 3H domain (so-called to reﬂect the
conserved three-histidine signature), a widely distributed
small-molecule-binding domain found in many signal
transduction proteins and enzymes such as TrkA-module
A
BC
Figure 2. Structural and functional features of the NiaR family. (A) The maximum-likelihood tree of the NiaR family of transcriptional regulators.
Genome context (chromosomal clustering) of the niaR genes is reﬂected by the color of squares with colors as in Figure 1A. The NiaR proteins from
T. maritima and B. subtilis studied in this work are outlined. The NiaR proteins recognizing type I and type II DNA motifs are shown by black
and red lines, respectively. The numbers indicate the number of bootstrap replications, out of 100, that support each node on the tree.
(B) The arrangement of DNA-binding (HTH) and putative niacin-binding (3H) domains in the 3D structure tmNiaR (PDB accession number 1J5Y);
(C) The NrtR recognition DNA motifs of type I and type II are shown by their respective sequence logos.
Nucleic Acids Research, 2008, Vol. 36, No. 6 2037proteins or 2-phosphoglycerate kinase (38). Signiﬁcant
amino acid sequence conservation of both domains,
including three highly conserved histidine residues in the
putative eﬀector-binding 3H domain (His85, His153 and
His155 in bsNiaR), supports the anticipated conservation
of function within the entire NiaR family (see multiple
alignment in Supplementary Figure S2). The analysis of
genome context and the reconstruction of the NiaR
regulons (see below) provided additional strong evidence
of the proposed role of the NiaR proteins in transcrip-
tional regulation of NAD synthesis in all analyzed
bacterial species.
Genome context of the niaR genes. Clustering of genes
on the prokaryotic chromosome, a major technique
of genome context analysis, provides the key evidence
of functional coupling of genes in pathways (39).
Particularly, bacterial transcriptional factors often occur
close on the chromosome to the genes that they regulate
(40,41). Indeed, the B. subtilis yrxA (niaR) gene is located
next to its target operon, nadBAC. The same chromoso-
mal arrangement is retained in other Bacillales genomes
except for the Staphylococcus and Oceanobacillus species
that lack both niaR and the de novo NAD biosynthetic
genes. Among niaR-containing species, the Lactobacillales
and Streptococcaceae also lack the de novo NAD
biosynthesis genes, and in many of them niaR is found
clustered on the chromosome with the niacin salvage gene
pncB and with hypothetical transporter genes (Figure 1B).
In Fusobacterium nucleatum and Alkaliphilus metalliredi-
gens, niaR is apparently cotranscribed with the upstream
nadABC operon, whereas in the Thermotogales it forms
an operon with an ortholog of the B. subtilis yceI (niaP)
gene (tentatively assigned a role in niacin uptake, see
below). This analysis further conﬁrmed functional cou-
pling between the NiaR regulator and NAD metabolism
(Figure 2A) and deﬁned a training gene set to analyze
conserved upstream DNA sequences and to derive
putative NiaR-binding motifs.
NiaR-binding sites and regulon members. A comparative
genomic approach was eﬃciently applied for prediction of
DNA-binding motifs for a variety of transcription factors
in a broad range of bacterial genomes (18,26,27,35,36,42).
Using this approach in this study, we tentatively identiﬁed
NiaR-binding sites in 35 bacterial species with completely
sequenced genomes (see Table 1 and Supplementary
Table S2). For the Firmicutes group, the training set
included upstream regions of the nadABC operon from
12 genomes. The SignalX program applied to this training
set derived a candidate 22-bp NiaR-binding motif with the
imperfect inverted repeat symmetry (Figure 2C). To assess
signiﬁcance of this motif (designated here type I) we
deﬁned the level of nucleotide conservation within the
respective DNA segments in related bacteria by a
phylogenetic footprinting method (43). Multiple align-
ments of the nadABC operon upstream regions from
the Bacillus and Clostridium species revealed a high
level of conservation in predicted NiaR-binding sites
(Supplementary Figure S3). In B. subtilis, the predicted
NiaR-binding site overlaps the  10 promoter box and the
transcriptional start site of the nadB gene (17), consistent
with the proposed role of NiaR as a transcriptional
repressor.
A recognition proﬁle capturing the identiﬁed NiaR-
binding sites was constructed and used to detect their
additional occurrences and new members of the NiaR
regulon in all analyzed genomes (see Supplementary
Table S2). A threshold in the site scanning was set at the
lowest score observed within the training set. In addition
to the genes of the de novo pathway, candidate NiaR-
binding sites were found upstream of genes involved in
salvage of niacin (pncA and pncB) and uptake of RNam
(pnuC). The second occurrence of an NiaR-binding site in
the genome of B. subtilis and several other Bacillales was
detected upstream of the uncharacterized gene yceI (niaP)
encoding a transmembrane protein of the MFS transpor-
ter family. This provided additional support for the
inferred role of the NiaP protein family in niacin utiliza-
tion (see next section for a more detailed analysis). Due to
the important functional implications of this inference,
we chose to experimentally assess binding of bsNiaR to
both DNA target sites identiﬁed in B. subtilis.
Two additional nonorthologous families of putative
transporters were identiﬁed among NiaR regulon mem-
bers in other genomes of the Bacillus/Clostridium group,
represented by BH3254 (named niaY)i nB. halodurans,
and Spy1425 (niaX)i nStreptococcus pyogenes (see
Table 1, Figure 1B and next section for a more detailed
analysis). The identiﬁed candidate NiaR-binding sites
show a signiﬁcant conservation in closely related species
(as illustrated by multiple alignments in Supplementary
Figure S3). An observed overlap between these sites and
putative promoter elements of downstream genes is
consistent with the negative (repressor) mode of NiaR
regulation, as previously proposed for the nadABC operon
in B. subtilis (16).
Apart from the Bacillus/Clostridium group, candidate
NiaR-binding sites identiﬁed in Fusobacterium lineage
generally conform to the type I DNA motif deﬁned above.
An imperfect inverted repeat 50-TTTATTGTCTTGTCA
ATAAA-30 in the promoter region of the F. nucleatum
nadABC-niaR operon has a conserved core (underlined)
and divergent AT-rich ﬂanking regions. At the same time,
no similar DNA motifs could be detected in the available
genomes of the Thermotogales. We used the phylogenetic
footprinting approach (43) to identify the type II NiaR-
binding motif in this taxonomically distant group of
bacteria. In the de novo NAD synthesis of T. maritima, the
common bacterial aspartate oxidase (NadB) is replaced by
a nonorthologous aspartate dehydrogenase (NadBII) (44).
Multiple alignment of DNA regions upstream of
the nadBII-nadC-nadA operon (TM1643–TM1645 in
T. maritima), which is present in three compared
Thermotoga genomes revealed a highly conserved 17-bp
imperfect inverted repeat 50-TTTACAGCAGGTGTA
AA-30 (symmetrical nucleotides are underlined) located
between the candidate  35 and  10 promoter boxes
(Figure 2C and Supplementary Figure S3). Remarkably,
the identical DNA sequence was detected upstream of the
niaR-niaP operon (TM1602-TM1603 in T. maritima). This
operon and the respective DNA site are conserved in
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T. lettingae. The latter species lacks the de novo biosynth-
esis operon, and it appears to be fully dependent on the
niacin salvage pathway for NAD synthesis. Although the
genes composing this pathway (pncAB) do not belong to
the NiaR regulon in Thermotoga species, niacin salvage in
these organisms may still be regulated since the expression
of the putative NiaP transporter depends on NiaR. Based
on these observations, we hypothesized that the identiﬁed
DNA signal represents the type II NiaR-binding motif,
involved in coregulation of the de novo NAD biosynthetic
operon and the niaR-niaP genes in Thermotogales. This
prediction was experimentally tested by the EMSA
approach using the puriﬁed recombinant tmNiaR (as
described below). Despite the apparent diﬀerence in the
sequence of NiaR-binding motifs in Firmicutes and
Thermotogales, one may notice a mirror arrangement of
the conserved triplets, TGT-(N5)-ACA versus ACA-(N4)-
TGT, in the two motifs (Figure 2C). The latter may reﬂect
the diﬀerence in a relative orientation of the NiaR
subunits that are expected to interact with DNA in the
dimeric form.
Candidate niacin transporters. Utilization of the exogen-
ous Nam includes its uptake followed by a deamidating
(PncA/PncB-dependent) or nondeamidating (NadV-
dependent) conversion to NaMN or NMN precursors of
NAD (Figure 1A). The salvage of NA, a deamidated form
of vitamin B3, is performed by a single enzyme (PncB)
upon NA uptake mediated by the same or diﬀerent
transporters. Notwithstanding the importance of the
salvage pathways, especially for bacterial species that
lack de novo biosynthesis (e.g. many pathogens), relatively
little is known about niacin uptake. Although several
studies in various bacterial species pointed to the existence
of active transport (45,46), no speciﬁc transporter genes
have been identiﬁed so far. A high-aﬃnity NA permease
identiﬁed in Saccharomyces cerevisiae belongs to the yeast-
speciﬁc DAL5 family and does not have homologs in
bacteria (47). As already mentioned, regulon and genome
context analysis was previously used to predict novel
transporter genes in a number of metabolic subsystems [as
reviewed in (19)]. The analysis of the NiaR regulon in this
study implicated three diﬀerent families of uncharacter-
ized membrane proteins (named NiaP, NiaX, and NiaY)
as putative niacin transporters in three diﬀerent groups of
analyzed bacterial species.
The proteins of the NiaP family contain 10 predicted
TMSs and belong to the MFS superfamily of transporters
with various speciﬁcities to sugars and carboxylic acids
(Pfam accession number PF00083). NiaP displays a
detectable sequence similarity to the benzoate transporter
BenK of Acinetobacter sp. (48) and 4-hydroxybenzoate
permease PcaK from Pseudomonas putida (49) (see multi-
ple alignment in Supplementary Figure S4). Importantly,
these two aromatic compounds are quite similar to NA
(Figure 3A). The observed functional coupling of the
NiaP family with NAD biosynthesis is strengthened by
the evidence coming independently from two divergent
groups of bacteria, the Bacillus and Thermotoga species.
As discussed above, the niaP (yceI) gene in B. subtilis is
a predicted member of the NiaR regulon, whereas its
ortholog in T. maritima (TM1603) forms a self-regulated
operon with the upstream niaR regulator gene (Table 1
and Figure 1B). Notably, all analyzed niaP-containing
genomes also contain niacin salvage genes, whereas in
some of the Lactobacillales species that lack a de novo
NAD biosynthesis pathway, niaP is the only NiaR-
regulated gene. NiaP orthologs are also found in
bacterial species that do not contain NiaR (e.g. in the
Proteobacteria and Actinobacteria) and even in the
Metazoa (see the phylogenetic tree in Figure 3B and
the distribution of genes in Supplementary Table S1).
A likely conservation of the NiaP function in a broad
range of bacteria not having the NiaR regulon, is
additionally supported by: (i) co-occurrence of the niaP
(uptake) and pncB (salvage) genes in most genomes;
(ii) chromosomal clustering of the niaP and pncB genes
in a divergent Deinococcus branch; and (iii) regulation by
a NAD-related transcriptional regulator of the NrtR
family, as in Acinetobacter sp. [see the accompanying
paper (50)].
The second candidate transporter family NiaX
(represented by Spy1425 in S. pyogenes) is present in all
Streptococcaceae, in four Clostridiales species, and in
Enterococcus faecalis (Table 1). In many genomes, the
niaX gene is located adjacent to niaR on the chromosome
(Figure 1B). NiaX is an integral membrane protein with
four predicted TMSs showing no detectable similarity
with any known or unknown protein in any other genome
beyond this group. Most NiaX-containing species (among
them many pathogens) lack the de novo NAD biosynthesis
but possess the PncA–PncB salvage pathway. The NiaR
regulon in two Streptococcus species and Clostridium
tetani contains the niaX and pncA genes, whereas in
Thermoanaerobacter tengcongensis it includes the niaX and
pncB genes. These observations support possible involve-
ment of NiaX in niacin transport.
The third novel gene in the NiaR regulon (represented
by BH3254 in B. halodurans) encodes a hypothetical
transmembrane protein with nine predicted TMSs. This
protein family, named NiaY, is present in a limited
number of bacterial species and shows no detectable
similarity with any proteins of known function. In Bacillus
clausii, Exiguobacterium sp. and Clostridium diﬃcile, the
niaY gene is preceded by a strong NiaR-binding site
(Table 1), whereas in A. metalliredigens it belongs
to the NiaR-regulated nadABC-niaR-niaY gene cluster
(Figure 1B). In addition to these species, members of
the NiaY family were identiﬁed only in Staphylococcus
saprophyticus, Mannheimia succiniciproducens, Treponema
denticola and F. nucleatum. Notably, niaY genes do
not occur in genomes that contain other candidate
niacin transporter genes (niaP, niaX), whereas they
always co-occur with the salvage gene pncB. This
phyletic pattern provides an additional support for
the proposed functional assignment of the NiaY protein
family.
In summary, the bioinformatics analysis performed in
this study allowed us to tentatively identify two types of
DNA motifs that correspond to the binding sites of
transcriptional regulators of the NiaR family. Genomic
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regulons in 35 diverse bacterial genomes led to the
prediction of candidate genes for previously uncharacter-
ized niacin transporters. The following key inferences were
chosen for the experimental testing: (i) NrtR-binding sites
detected in B. subtilis and T. maritima were assessed using
EMSA with recombinant puriﬁed bsNiaR and tmNiaR
proteins; (ii) the predicted role of the NiaP family in
niacin uptake was tested by growth studies in B. subtilis
yceI gene knockout and heterologous expression of yceI in
E. coli.
Experimental testing of NiaR binding topredicted
DNA targetsin T.maritima andB. subtilis
Interaction of the NiaR proteins with DNA operator
regions containing candidate NiaR-binding sites was
assessed in vitro by EMSA. For validation experiments,
we have chosen two representatives of the NiaR family,
YrxA from B. subtilis (bsNiaR) and TM1602 from
T. maritima (tmNiaR). The choice of these two organisms
was dictated by the following considerations: (i) conserva-
tion of regulatory function between highly divergent
A
B
Figure 3. Structural features of the NiaP family. (A) Topology prediction for a niacin (NiaP) and a related benzoate (BenK) transporters from the
MFS superfamily. Bacillus subtilis NiaP and Acinetobacter sp. BenK share 27% sequence identity and are composed of 12 predicted transmembrane
helices shown by cylinders. (B) Maximum-likelihood tree of the NiaP family of niacin transporters. Names of taxonomic groups are given in red.
Genes predicted to be regulated by one of the three NAD regulons (NadR, NrtR or NiaR) are highlighted. The chromosomal clusters of the niaP
genes with NAD regulatory and metabolic genes are given in blue text. The numbers indicate the number of bootstrap replications, out of 100, that
support each node on the tree. Multiple alignment of NiaP proteins, as well as of BenK and other homologous transporters is provided in
the Supplementary Figure S4. The NiaP protein from B. subtilis studied in this work is outlined.
2040 Nucleic Acids Research, 2008, Vol. 36, No. 6representatives of the NiaR protein family, especially at
such a large phylogenetic distance as between the
Bacillales and Thermotogales lineages, would provide an
additional support for the functional assignment of the
entire family; (ii) predicted NiaR-binding sites in these
species represent the two distinct DNA motifs character-
istic of the NiaR family; (iii) the previously described
bsNiaR binding with one of the two target sites in
B. subtilis (16) provided us with a positive control for
EMSA experiments; and (iv) the availability of the
recently solved 3D structure of tmNiaR (37) as well as
of diﬀractable crystals of bsNiaR (Zhang,H., unpublished
data) sets the stage for structure-functional studies.
Incubation of the puriﬁed recombinant bsNiaR protein
with its predicted cognate DNA segments (bs_nadB_87
and bs_niaP_87)a t3 7 8C, in the presence of 0.3mM NA
and nonspeciﬁc competitor (negative control DNA,
tm_pncA_111) followed by PAGE and Syber Green
staining, conﬁrmed the speciﬁc bsNiaR binding to both
target sites (Figure 4A and B). These results demonstrated
that in addition to the previously described regulation of
the yrxA/nifS–nadBCA divergon (16), the NiaR regulon in
B. subtilis includes the remote yceI (niaP) gene with a
suggested role in niacin uptake.
The EMSA results obtained upon incubation of
tmNiaR with each of the two predicted target DNA
segments (tm_nadB_68 and tm_niaR_68) from the
upstream regions of the T. maritima nadBII-nadA-nadC
and niaR-niaP operons, respectively, are illustrated in
Figure 4C and D. The incubation was performed at 758C,
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Figure 4. Electrophoretic mobility shift assays (EMSA) to assess the interactions of NiaR proteins from B. subtilis (bsNiaR) and T. maritima
(tmNiaR) with their cognate DNA signals. (A) Sequences of DNA fragments used in EMSA assays. Candidate NiaR-binding sites are shown in gray
boxes, and promoter elements are shown by solid lines for the known B. subtilis nadB promoter (17) and by dotted lines for the predicted promoters.
(B) Target DNA segments bs_yceI_87 and bs_nadB_87 (20 nM) were incubated for 30min at 378C with or without 20mM of bsNiaR in the presence
of 0.3mM NA and analyzed by EMSA. (C) and (D) EMSA of DNA segments tm_niaR_68 and tm_nadB_68 (20nM) after incubation for 30min at
758C with increasing concentrations of tmNiaR (0–40mM) in the presence or absence of the eﬀector, 0.3mM NA. A negative control DNA segment
tm_pncA_111 (without NrtR motif) was added to all incubation mixtures as a nonspeciﬁc competitor.
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T. maritima, as only weak binding was observed at 378C
(data not shown). For both targets a clear gel mobility
shift was observed in the presence of 0.3mM NA (added
to both the incubation mixture and the gel). Under these
experimental conditions, the shift of the speciﬁc 68-bp
DNA band was essentially complete at tmNiaR concen-
tration above 10mM, whereas no change in the 111-bp
nonspeciﬁc competitor DNA band (tm_pncA_111) could
be detected at up to 40mM tmNiaR. Exclusion of NA
from the incubation and PAGE buﬀers led to substantial
changes in the tmNiaR–DNA interactions: (i) the shift
of either segment remained incomplete even at 40mM
tmNiaR and (ii) even at a high concentration of tmNiaR, a
substantial fraction of shifted DNA appeared as a smear,
likely due to the microheterogeneity and/or instability of
the complex in the absence of the NA eﬀector. This is in
contrast to a sharp binary distribution between nonshifted
and fully shifted bands observed in the presence of NA.
These observations are similar to those previously
reported, where the presence of the NA eﬀector led to
both, increased DNA-binding aﬃnity and possible change
in the stoichiometry of the bsNiaR–DNA complex, as
deduced from the change in the mobility of a shifted band
(referred to as supershift) (16).
Overall, this analysis of two representative NiaR
proteins provided a suﬃcient experimental conﬁrmation
of the target NiaR-binding sites and NiaR-regulated genes
tentatively identiﬁed by comparative genomic techniques
(as described in the previous section). We believe that in
addition to speciﬁc ﬁndings related to the NiaR regulon in
B. subtilis and T. maritima, these results constitute an
additional supportive evidence of the similar assignments
made for the members of the NiaR family in other species.
Experimental assessment ofthe predicted NiaP transporter
fromB. subtilis
To test a proposed involvement of the NiaP protein family
in niacin transport, we cloned the gene yceI (niaP) from
B. subtilis and assessed the eﬀect of its overexpression on
the growth rate of an E. coli BW25113 (nadA) mutant in
the minimal medium supplemented with limiting amount
of Nam. This strain, made available to us from the Keio
collection of E. coli single-gene deletion mutants (33),
requires Nam or NA to grow on the minimal medium as it
has a disrupted de novo synthesis making it fully
dependent on the salvage of exogenous niacin (via the
PncA-PncB pathway, see Figure 1A). Although E. coli has
an intrinsic ability to uptake niacin via a yet unknown
mechanism (46), we speculated that overexpression of the
B.subtilis yceI gene in the E. coli nadA mutant could
increase the eﬃciency of Nam uptake and accelerate the
strain growth at suboptimal concentrations of Nam.
Indeed, a substantial (up to  6fold) growth rate accel-
eration was observed in this engineered strain compared to
the control strain carrying an empty vector plasmid at
0.16mM Nam (Figure 5). The diﬀerence between the
growth curves was smaller at higher concentrations of
niacin, becoming negligible at above 1mM niacin (data
not shown).
An additional veriﬁcation of the bsNiaP functional
assignment was obtained using a diﬀerent approach based
on growth inhibition by 6ANam, a toxic analog of niacin.
This compound is known to suppress bacterial growth by
entering the regular PncA-PncB salvage pathway and
ultimately converting to NAD antagonist (6-amino-NAD)
(51,52). Assuming that NiaP would facilitate the uptake of
the niacin analog, we expected to observe the increased
sensitivity of E. coli containing the same yceI expression
plasmid to growth suppression by 6ANam. This experi-
ment was performed in the strain of E. coli containing an
undisrupted de novo pathway transformed with the same
expression plasmid containing the B. subtilis yceI gene.
A signiﬁcant diﬀerence in the growth rate between this
strain and an isogenic control strain transformed with an
empty vector was observed in a narrow range of 6ANam
concentration 7.5–15mM (Figure 6A). The growth of both
strains was completely suppressed at 6ANam concentra-
tions above 150mM, whereas no diﬀerence in their growth
rates was observed in the absence of 6ANam.
A similar approach was used to test whether bsNiaP
contributes to niacin uptake in its natural host. It was
accomplished by comparing the growth of B. subtilis
knockout mutant with disrupted yceI (niaP) gene versus a
control strain with intact yceI in the presence of 6ANam.
The expectation was that inactivation of the yceI gene
would cause resistance to the toxic niacin analogs.
However, the growth of this knockout mutant was
rather eﬃciently suppressed by 6ANam pointing to the
existence of the NiaP-unrelated niacin uptake mechanism
in B. subtilis. At the same time, a substantial diﬀerence in
the growth rate of the two strains was indeed observed in
the presence of 0.75–1.5mM 6ANam (Figure 6B), whereas
no diﬀerence in the respective growth curves could be
detected in the absence of 6ANam. In the presence
of another toxic niacin analog, 6-amino-NA (6ANA),
Figure 5. An accelerated growth of E. coli nadA mutant carrying yceI
gene in the minimal media supplemented by a limiting concentration of
nicotinamide (0.16mM). The plasmid containing the B. subtilis yceI
gene was introduced into the E. coli nadA mutant lacking de novo
NAD biosynthesis, whereas the same strain with an empty vector was
used as a negative control (black and open squares, respectively).
2042 Nucleic Acids Research, 2008, Vol. 36, No. 6the largest diﬀerence in the growth rate of the two strains
was observed at 1–2.5mM 6ANA. These observations
suggest that bsNiaP contributes to the uptake of both
amidated and deamidated forms of niacin. The obtained
results also revealed that, in addition to NiaP, B. subtilis
must have another, hitherto-unknown transport system
for niacin uptake.
Overall, the cumulative evidence generated in the three
diﬀerent types of experiments described above provided
strong support for the tentative functional assignment
proposed for the NiaP family by comparative genomic
analysis and reconstruction of the NiaR regulon. To our
knowledge, this is the ﬁrst report implicating a protein
family in niacin uptake in bacteria.
DISCUSSION
The comparative genomic approach was applied to
characterize a novel NiaR regulon for transcriptional
control of NAD metabolic genes in bacteria. The niacin-
responsive transcription factor NiaR (YrxA) was
originally identiﬁed and characterized as a nicotinic
acid-responsive repressor of the de novo NAD biosynthesis
operon in B. subtilis (16). NiaR orthologs were found in
30 out of 45 species from the Bacillus/Clostridium group
(Firmicutes), as well as in the deeply diverged groups,
the Fusobacteria and Thermotogales (Supplementary
Table S1). Two distinct types of DNA-binding sites of
NiaR were identiﬁed, type I operator characteristic of
the Firmicutes and Fusobacteria, and type II in the
Thermotogales (Figure 2A and C). Despite the apparent
overall dissimilarity, both types of operators share
palindromic signature sequences, TGT and ACA, albeit
in opposite orientation (Figure 2A and C). Comparison of
closely related species showed high conservation of
candidate NiaR-binding sites in the promoter regions
of target genes (Supplementary Figure S3).
To validate the predicted NiaR-binding sites of both
types, the NiaR proteins from two organisms, B. subtilis
(bsNiaR) and T. maritima (tmNiaR), were cloned,
puriﬁed, and assessed in EMSA assays for their ability
to bind DNA fragments containing their target DNA
sites. The results of these experiments (Figure 4) conﬁrmed
both the second type I operator site predicted in B. subtilis
and the predicted DNA sites of type II in T. maritima.
They also conﬁrmed that, as previously shown for bsNiaR
(16), NA is a likely eﬀector (corepressor) for the
phylogenetically divergent tmNiaR. Comparative 3D
structural studies are underway to assess mechanistic
details of the interactions with DNA and the eﬀector in
these two distant representatives of the NiaR family.
A combination of comparative genomic techniques,
including positional gene clustering, phylogenetic foot-
printing of regulatory sites and metabolic reconstruction,
helped us establish the details of the NiaR regulon
organization in 35 bacterial species (Figure 1A and
Table 1). In 18 genomes including species from the
Firmicutes, Fusobacteria and Thermotogales groups,
NiaR regulates de novo biosynthesis operon nadABC.
Less frequent is the NiaR regulation of the niacin salvage
genes pncB (in Lactobacillus plantarum) and/or pncA (in
S. pyogenes, Streptococcus equi, and C. tetani) and the
RNam salvage transporter pnuC (in S. pneumoniae and
Streptococcus mutans). In addition, the NiaR regulon
AB
Figure 6. Growth studies in the presence of 6ANam, a toxic analog of Nam. (A) An enhanced 6ANam sensitivity (growth suppression) of E. coli
strain overexpressing the B. subtilis yceI gene is observed when grown in minimal medium supplemented by 6ANam compared to the control strain
containing empty vector. Both strains have an intact de novo NAD biosynthesis. (B) In similar growth studies the B. subtilis (yceI
 ) mutant displayed
a decreased 6ANam sensitivity (faster growth) compared to the B. subtilis strain with an intact yceI gene (carrying the same transposon insert in the
unrelated gene ypaA as a negative control).
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encoding membrane proteins of unknown function, to
which we here tentatively assigned a role in niacin uptake.
Of those, the most abundant NiaP family is present in 10
NiaR-containing species (Bacilli, Lactobacilli and
Thermotogales) as well as in a number of species that do
not contain the NiaR regulator. Among two other
families, NiaX is present in twelve genomes
(Streptococci and Clostridia), and NiaY is present in ﬁve
genomes (Bacilli and Clostridia). The proposed involve-
ment of these gene families in niacin uptake is supported
by several lines of genomic evidence: (i) predicted
coregulation with NAD biosynthesis and niacin salvage
genes; (ii) clustering on the chromosome with the niaR
genes; (iii) nonoverlapping (complementary) phyletic
patterns of the genome occurrence; (iv) regulation by
NiaR in species lacking the nadABC genes and fully
dependent on niacin salvage for NAD synthesis; and (v)
co-occurrence with the niacin salvage genes pncB-pncA
(Table 1).
Although niacin uptake has been studied in many
species, both bacterial, such as E. coli (46) and E. faecalis
(45), and eukaryotic, such as yeasts (47) and mammals
(53,54), the knowledge of the respective transport systems
and mechanisms is quite limited. The only NA-speciﬁc
permease was identiﬁed in yeast (47), and the absence of
its orthologs in other lineages suggests that other niacin
transporters are yet to be identiﬁed.
The predicted niacin transporter NiaP, a member of the
NiaR regulon in Firmicutes and Thermotogales, belongs
to other NAD-related regulons in other bacterial species
(Figure 3B). Particularly, in two Actinobacteria and two
Lactobacilli, NiaP is a member of the NrtR regulon,
which is described in the accompanying paper (50).
Furthermore, an NiaP ortholog detected in a enterobac-
terium Proteus mirabilis is presumably regulated by
binding of the NadR repressor to its characteristic
operator site (TGTTTAGTATACTAAACA) in the
upstream region of the respective gene. The NiaP
transporters belong to the MFS superfamily of transpor-
ters that catalyze uniport, solute:cation symport and
solute:cation antiport of a great variety of metabolites
(55). NiaP is most similar to the aromatic acid/H
+
symporters PcaK from Pseudomonas spp. and BenK from
Acinetobacter spp. involved in 4-hydroxybenzoate and
benzoate uptake, respectively (48,49).
We selected a representative of the NiaP family encoded
by the yceI gene in B. subtilis for the experimental testing
of its proposed involvement in niacin uptake. Three types
of growth experiments were performed to test for: (i) the
growth acceleration of E. coli (nadA
 ) mutant strain in
minimal medium supplemented with limiting concentra-
tions of Nam, as a result of overexpression of the
B. subtilis gene yceI; (ii) the increased sensitivity of
E. coli (nadA
+) to the growth suppression by a toxic
analog of Nam (6ANam), as a result of overexpression of
the B. subtilis gene yceI and (iii) the increased resistance of
the B. subtilis (yceI
 ) mutant to growth suppression by
toxic niacin analogs (6ANam and 6ANA). The results of
these experiments (Figures 5 and 6) allowed us to conclude
that bsNiaP is involved in niacin transport in B. subtilis,
although there exist additional, unknown mechanism for
niacin uptake. It is important to emphasize that although
the performed experiments provided suﬃcient support for
the predicted functional assignment of the NiaP family,
additional studies are necessary to establish its actual
mechanism, energy dependence and kinetic parameters, as
well as to elucidate the mechanism of NiaP-independent
niacin uptake.
High-scoring homologs of NiaP are widely distributed
among Gram-positive and Gram-negative bacteria
(Supplementary Table S1), and they are also present in
eukaryotic genomes including nematodes, insects and
mammals showing substantial (up to 30%) sequence
identity with their bacterial counterparts (Supplementary
Figure S4). Although the mechanism of niacin transport
was characterized in human intestinal epithelial and liver
cells, a gene encoding the respective transporter is yet
unknown. At the same time, the human homolog of NiaP,
a synaptic vesicle 2-related protein (SVOP) expressed in
brain and endocrine cells, was extensively studied but its
physiological and molecular function remained obscure
(56). It is tempting to speculate that human SVOP and its
orthologs in other mutlicellular eukaryotes constitute a
plausible candidate for a missing niacin transporter in
these organisms. This hypothesis, however farfetched it
may seem due to the evolutionary distance and well-
anticipated diﬀerences between bacterial and eukaryotic
membrane transport systems, is supported by a precedent
in the ﬁeld of vitamin transport. Indeed, the human
homolog of the bacterial pantothenate (vitamin B5)
transporter of the Solute:Sodium Symporter family (e.g.
PanF in E. coli) was implicated in uptake of B5 (and
possibly some other vitamins) in human cells (57).
This work and the accompanying study (50) demon-
strated a signiﬁcant variability of regulatory strategies
for the transcriptional control of NAD metabolism in
diﬀerent bacterial species (see Supplementary Table S1
that summarizes the distribution of NAD metabolic and
regulatory genes across genomes). This variability paral-
lels substantial variations in the topology of NAD
biosynthetic pathways [as illustrated in the ‘NAD and
NADP biosynthesis’ subsystem provided by the SEED
database (http://theseed.uchicago.edu/) and brieﬂy dis-
cussed in (58)] and, more importantly, a variety of
bacterial habitats and lifestyles. Although the NiaR
regulatory mechanism bears some analogy with NadR
regulation previously studied in Enterobacteria (e.g.
suppression of the de novo biosynthesis enhanced by
interactions with a corepressor), fundamental diﬀerences
between these two regulatory strategies are apparent.
Whereas NadR blocks all biosynthetic routes to NAD as
long as NAD concentration is above threshold (NAD
operates is an eﬀector of NadR), NiaR tends to switch the
organism from the de novo biosynthetic route to niacin
salvage as long as niacin is available at the level suﬃcient
to operate as an NiaR corepressor. On the other hand,
niacin may also regulate its own uptake to maintain NAD
homeostasis at the desired level as the genes of the
downstream biosynthetic machinery (NadD and NadE)
appear to be constitutively expressed, or at least not
regulated by NiaR. Regulation of the niacin salvage
2044 Nucleic Acids Research, 2008, Vol. 36, No. 6enzymes (PncA and PncB) by NiaR is relatively rare, and
happens only in species that lack a de novo biosynthetic
route. Both NadR and NiaR regulatory strategies are
dramatically diﬀerent from the NrtR regulatory network
described in the accompanying paper (50). The latter
regulon includes the entire NAD biosynthetic machinery,
including the downstream enzymes. The derepression
appears to be triggered by the accumulation of NAD
degradation products (e.g. ADP ribose that operates
as NrtR antirepressor) likely interpreted by the cell as
depletion of the NAD pool which thus needs to be
replenished.
In summary, this study provided a comprehensive
bioinformatic analysis of the NiaR regulon that constitu-
tes a system of transcriptional regulation of NAD
synthesis in several groups of Gram-positive bacteria.
The key conjectures delivered by this analysis, two types of
NiaR-binding DNA motifs and one of the three predicted
families of niacin transporters, were experimentally
validated providing additional support for these speciﬁc
ﬁndings as well as for the reconstruction of the entire
NiaR regulon. Despite the implications of this and the
accompanying study (50), the mechanisms and the speciﬁc
genes involved in the regulation of NAD synthesis as well
as in the uptake of its precursors in many groups of
bacteria, remain to be elucidated.
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